Table 2.
NLR Stability and Clinical Outcomes in AECOPD Patients
| Persistent High Group (n=109) | Decreased Group (n=175) | Increased Group (n=216) | Persistent Low Group (n=341) | P | |
|---|---|---|---|---|---|
| Hospital mortality | 1(0.9)a,b | 8(4.6)a | 2(0.9)a,b | 1(0.3)b | 0.001 |
| Transfer to ICU | 14(12.8)a | 18(10.3)a | 2(0.9)b | 5(1.5)b | <0.001 |
| IMV | 9(8.3)a | 8(4.6)a,b | 2(0.9)b,c | 2(0.6)c | <0.001 |
| LOS>14 days | 72(66.1)a | 112(64.0)a | 28(13.0)b | 39(11.4)b | <0.001 |
| Adverse hospital outcomes | 79(72.5)a | 120(68.6)a | 30(13.9)b | 42(12.3)b | <0.001 |
| Hospital cost | 23021(15,772–31502)a | 21282(16,133–30409)a | 14086(10,949–17666)b | 14082(11,153–17619)b | <0.001 |
Note: Different letters indicate significant differences among groups.
Abbreviations: NLR, neutrophil-lymphocyte ratio; AECOPD, acute exacerbation of chronic obstructive pulmonary disease; ICU, intensive care unit; IMV, intensive mechanical ventilation; LOS, length of hospital stay.